Gripmax® Nose (Tablets) Instructions for Use
Marketing Authorization Holder
UNIPHARM, LLC (Russia)
Manufactured By
Grokam GBL, sp. z o.o. (Poland)
Groups
MASTER PHARM, S.A. (Poland)
For
UNIPHARM LABORATORIES, Limited (Ireland)
Dosage Form
| Gripmax® Nose | Coated tablets: 30 or 60 pcs. |
Dosage Form, Packaging, and Product Composition
Coated tablets, weighing 321 mg.
| 1 tab. | 1 dose (3-6 tab.) | |
| Bromelain (from Ananas comosus) | 27.5 mg | 82.5-165 mg |
| Extract of creeping thyme herb (Thymus serpyllum) | 55 mg | 165-330 mg |
| Extract of common ivy leaves (Hedera helix L.) | 1.38 mg | 4.14-8.28 mg |
| Extract of common mallow flowers (Malva sylvestris L.) | 55 mg | 165-330 mg |
| Extract of purple coneflower herb (Echinacea purpurea L. Moench.) | 55 mg | 165-330 mg |
| Extract of manna gum leaves (Eucalyptus viminalis Labill.) | 17.37 mg | 52.11-104.22 mg |
| L-aspartic acid (vit. C) | 25 mg | 75-150 mg |
Excipients : microcrystalline cellulose (filler), hypromellose (glazing agent), maltodextrin, calcium carbonate (colorant), silicon dioxide (anticaking agent), magnesium salts of fatty acids (anticaking agent), fatty acids (emulsifier), copper chlorophyllin complex (colorant).
Does not contain artificial colors or flavors.
30 pcs. – blisters (1) – cardboard packs.
30 pcs. – blisters (2) – cardboard packs.
Therapeutic Category
Dietary supplement for normalizing the condition of ENT organs, incl. for colds
Properties
Dietary supplement. A complex remedy with active natural components for nasal congestion and discharge.
It has the following effects: decongestant; secretolytic (mucolytic), secretomotor; anti-inflammatory; antiseptic (antiviral, antibacterial, antifungal); immunomodulatory; antihistamine.
The product helps cleanse the nasal sinuses of mucus and facilitate its elimination, ease breathing; reduce nasal congestion, swelling, discomfort, and burning in the nasal area; eliminate infectious pathogens (viruses, bacteria, fungi) in the nasal area and upper respiratory tract; accelerate the restoration of the nasal mucosa and upper respiratory tract and prevent the development of complications; improve the condition of the upper respiratory tract; boost immunity, reduce the likelihood of cold symptoms and infectious-inflammatory conditions of the nasal cavity.
Bromelain – a proteolytic enzyme, has analgesic, antiseptic, bactericidal, and anti-inflammatory properties.
Bromelain attenuates the development of allergic conditions of the respiratory tract by altering CD4+ and CD8+ T-lymphocyte populations. It has analgesic and anti-inflammatory effects.
Extract of creeping thyme herb contains the essential oil thymol, which has disinfectant, antibacterial, pronounced antioxidant, anti-inflammatory, and immunomodulatory effects.
Thyme herb extract has anti-inflammatory and expectorant effects.
Extract of common ivy leaves is rich in essential oils, which have an antibacterial effect.
The antitussive activity is due to the presence of α-hederin, which binds to β-adrenergic receptors and thereby causes relaxation of bronchial smooth muscle. It helps improve external respiratory function.
Extract of common mallow flowers, due to its content of terpenoid compounds, flavonoids, and anthocyanins, has a soothing effect on the nasopharyngeal mucosa and reduces throat swelling, irritation, and hoarseness.
It helps ease breathing, reduce throat tickling, thin sputum, and improve its expectoration. It has emollient, antibacterial, analgesic, and bacteriostatic effects on the upper respiratory tract mucosa.
Mallow polysaccharides have immunomodulatory and pronounced antioxidant properties.
Extract of purple coneflower herb, due to its content of lectin and alkaloids, has immunostimulating and virus-neutralizing activity.
It has a pronounced stimulating effect on the phagocytic activity of blood monocytes, tissue macrophages, and neutral granulocytes; enhances the production of cytokines by macrophages: TNF-α, If-β2, Il-1, Il-6, Il-10, which in turn increases resistance to fungi of the genus Candida.
Echinacea extract reduces the likelihood of developing an infectious process, leads to a reduction in the inflammatory focus, and has antioxidant potential.
Echinacea extract has anti-herpetic and anti-influenza activity, antibacterial activity against strepto- and staphylococci; pronounced antifungal activity against the most common causative agents of fungal diseases.
Echinacea extract has the ability to shorten the duration of nasal congestion.
Extract of manna gum leaves has strong antiseptic and pronounced antiviral, antioxidant, anti-inflammatory, and analgesic properties.
Manna gum leaf extract, being excreted through the bronchi, has an expectorant effect.
Vitamin C (ascorbic acid) – a water-soluble vitamin necessary for the normal development of connective tissue, regeneration and healing processes, resistance to various types of stress, ensuring normal immunological status of the body, and supporting hematopoiesis processes.
The most important functions of ascorbic acid are participation in the processes of collagen and elastin maturation, normalization of capillary permeability, in the processes of detoxification and elimination of toxic substances, drugs, and poisons from the body, and counteracting infectious pathogens.
Scope of Application
As a dietary supplement – an additional source of flavonoids, vitamin C, bromelain, hydroxycinnamic acid.
Used for nasal congestion accompanied by the formation of viscous secretion, difficulty breathing; impaired elimination of viscous secretion from the nasal sinuses; to boost local immunity (has an immunomodulatory effect).
ICD codes
| ICD-10 code | Indication |
| E54 | Deficiency of ascorbic acid |
| E63.8 | Other specified types of nutritional deficiency |
| J00 | Acute nasopharyngitis (common cold) |
| J01 | Acute sinusitis |
| J06.9 | Acute upper respiratory infection, unspecified |
| ICD-11 code | Indication |
| 5B56.Z | Vitamin C deficiency, unspecified |
| 5B7Z | Malnutrition, unspecified |
| 8D40.0 | Encephalopathy due to nutritional deficiency |
| CA00 | Acute nasopharyngitis |
| CA01 | Acute rhinosinusitis |
| CA07.0 | Acute upper respiratory tract infection of unspecified site |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take orally, 1-2 doses 3 times/day.
The duration of administration is from 7 days to 1 month. If necessary, the course can be repeated.
The frequency of use and duration of the course are set individually.
Contraindications
Hypersensitivity to the product components; pregnancy, breastfeeding period.
Use during pregnancy and lactation
Contraindicated for use during pregnancy and breastfeeding.
Special instructions
A dietary supplement, not a medicinal product.
Storage Conditions
Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer